default author photo

Andres Finzi

Centre de Recherche du CHUM

SCHOLARLY PAPERS

8

DOWNLOADS

407

TOTAL CITATIONS

8

Scholarly Papers (8)

Actions:
Email selected abstracts
1.

Safety and Efficacy of Inhaled IBIO123 for Severe COVID-19: A Randomised, Double-Blind, Dose-Ascending, Placebo-Controlled, Phase 1/2 Trial

Number of pages: 35 Posted: 06 Oct 2023
Sébastien M. Labbé, Bruno Maranda, Magali Lurquin, Pascal Brabant, Alexandre Fugère, Jean-François Larrivée, Djordje Grbic, Annie Leroux, Frédéric Leduc, Andres Finzi, Simon Gaudreau, Larry D. Mey and IBIO-INH-002 Investigators
Immune Biosolutions Inc, Immune Biosolutions Inc, Immune Biosolutions Inc, Immune Biosolutions Inc, Immune Biosolutions Inc, Immune Biosolutions Inc, Immune Biosolutions Inc, Immune Biosolutions Inc, Immune Biosolutions Inc, Centre de Recherche du CHUM, Immune Biosolutions Inc, Ryexo Clinical Research and Independent
Downloads 179 (422,345)

Abstract:

Loading...

COVID-19, monoclonal antibody, inhalation, therapy

2.

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects

Number of pages: 55 Posted: 01 Apr 2021
Madeleine Jennewein, Anna MacCamy, Nicholas Akins, Junli Feng, Leah Homad, Nicholas Hurlburt, Emily Seydoux, Yu-Hsin Wan, Andrew B. Stuart, Venkata Edara, Katharine Floyd, Abigail Vanderheiden, John R. Mascola, Nicole Doria-Rose, Lingshu Wang, Eun Sung Yang, Helen Y. Chu, Jonathan L. Torres, Gabriel Ozorowski, Andrew B. Ward, Rachel Whaley, Kristen Cohen, Marie Pancera, Juliana McElrath, Janet A. Englund, Andres Finzi, Mehul Suthar, Andrew T. McGuire and Leonidas Stamatatos
Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Emory University - Department of Pediatrics, Emory University - Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Emory University - Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, University of Washington - Division of Allergy and Infectious Diseases, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Pediatrics, Centre de Recherche du CHUM, Emory University - Center for Childhood Infections and Vaccines, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 47 (1,097,529)
Citation 4

Abstract:

Loading...

SARS-CoV-2, SARS-CoV-1, S2 subunit, RBD, NTD, neutralization, monoclonal antibodies, B.1.351

3.

Temporal Associations of B and T Cell Immunity with Robust Vaccine Responsiveness in a 16-Week Interval BNT162B2 Regimen

Number of pages: 53 Posted: 03 Feb 2022
Manon Nayrac, Mathieu Dubé, Gérémy Sannier, Alexandre Nicolas, Lorie Marchitto, Olivier Tastet, Alexandra Tauzin, Nathalie Brassard, Guillaume Beaudoin-Bussières, Dani Vézina, Shang Yu Gong, Mehdi Benlarbi, Romain Gasser, Annemarie Laumaea, Catherine Bourassa, Gabrielle Gendron-Lepage, Halima Medjahed, Guillaume Goyette, Gloria-Gabrielle Ortega-Delgado, Mélanie Laporte, Julia Niessl, Laurie Gokool, Chantal Morrisseau, Pascale Arlotto, Jonathan Richard, Cécile Tremblay, Valérie Martel-Laferrière, Andres Finzi and Daniel E. Kaufmann
University of Montreal, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), affiliation not provided to SSRN, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, affiliation not provided to SSRN, McGill University, Centre de Recherche du CHUM, University of Montreal, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, Centre de Recherche du CHUM, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM and University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)
Downloads 38 (1,209,354)

Abstract:

Loading...

Coronavirus, COVID-19, SARS-CoV-2, Spike glycoproteins, Longer interval mRNA vaccine regimen, CD4 T cell, CD8 T cell, CD4 T cell help, B cells, humoral responses, AIM assay, immunological memory

4.

Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice

Number of pages: 60 Posted: 31 Aug 2023
Irfan Ullah, Fanny Escudié, Ivan Scandale, Zoela Gilani, Gabrielle Gendron-Lepage, Fluer Gaudette, Charles Mowbray, Laurent Fraisse, Renee Bazin, Andres Finzi, Walther Mothes, Priti Kumar, Eric Chatelain and Pradeep Uchil
Yale University - Section of Infectious Diseases, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Yale University - Department of Microbial Pathogenesis, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Héma-Québec - Affaires Médicales et Innovation, Centre de Recherche du CHUM, Yale University - Department of Microbial Pathogenesis, Yale University - Section of Infectious Diseases, Drugs for Neglected Diseases Initiative (DNDi) and Yale University - Department of Microbial Pathogenesis
Downloads 33 (1,277,121)
Citation 1

Abstract:

Loading...

molnupiravir, favipiravir, nirmatrelvir, Inflammasome, VX-765, COVID-19, Convalescent Plasma, Bioluminescence imaging, Delta, Omicron, K18-hACE2

5.

Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy

Number of pages: 85 Posted: 01 Apr 2021
Irfan Ullah, Jérémie Prévost, Mark Ladinsky, Helen Stone, Maolin Lu, Sai Priya Anand, Guillaume Beaudoin-Bussières, Mehdi Benlarbi, Shilei Ding, Romain Gasser, Corby Fink, Yaozong Chen, Alexandra Tauzin, Guillaume Goyette, Catherine Bourassa, Halima Medjahed, Matthias Mack, Kunho Chung, Craig Wilen, Gregory A. Dekaban, Jimmy D. Dikeakos, Emily A. Bruce, Daniel E. Kaufmann, Leonidas Stamatatos, Andrew T. McGuire, Jonathan Richard, Pazgier Marzena, Pamela J. Bjorkman, Walther Mothes, Andres Finzi, Priti Kumar and Pradeep Uchil
Yale University - Section of Infectious Diseases, Centre de Recherche du CHUM, California Institute of Technology - Division of Biology and Biological Engineering, Yale University - Department of Microbial Pathogenesis, Yale University - Department of Microbial Pathogenesis, McGill University - Department of Microbiology and Immunology, Centre de Recherche du CHUM, Centre de Recherche du CHUM, Centre de Recherche du CHUM, Centre de Recherche du CHUM, University of Western Ontario, Uniformed Services University of the Health Sciences - Infectious Disease Division, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, Centre de Recherche du CHUM, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Regensburg - Department of Nephrology, Yale University - Section of Infectious Diseases, Yale University - Department of Immunobiology, The University of Western Ontario - Molecular Medicine Research Laboratories, University of Western Ontario - Department of Microbiology and Immunology, University of Vermont - Division of Immunobiology, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Centre de Recherche du CHUM, - Division of Vaccine Research, California Institute of Technology - Division of Biology and Biological Engineering, Yale University - Department of Microbial Pathogenesis, Centre de Recherche du CHUM, Yale University - Section of Infectious Diseases and Yale University - Department of Microbial Pathogenesis
Downloads 32 (1,290,922)
Citation 2

Abstract:

Loading...

SARS-CoV-2, COVID-19, nanoluciferase, bioluminescence imaging, neutralizing antibodies, convalescent patients, human ACE2 transgenic mice, monocytes, natural killer cells, monocytes, pathogenesis, inflammatory cytokines, Fc effector functions

6.

A Long Interval Between Priming and Boosting SARS-CoV-2 mRNA Vaccine Doses Enhances B Cell Responses With Limited Impact on T Cell Immunity

Number of pages: 44 Posted: 12 Aug 2022
Alexandre Nicolas, Gérémy Sannier, Mathieu Dubé, Manon Nayrac, Mark M. Painter, Rishi R. Goel, Mélanie Laporte, Halima Medjahed, Justine Williams, Nathalie Brassard, Julia Niessl, Laurie Gokool, Chantal Morrisseau, Pascale Arlotto, Cécile Tremblay, Valérie Martel-Laferrière, Andres Finzi, Allison R. Greenplate, E. John Wherry and Daniel E. Kaufmann
University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Pennsylvania - Institute for Immunology, University of Pennsylvania - Institute for Immunology, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Pennsylvania - Department of Systems Pharmacology and Translational Therapeutics, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, University of Pennsylvania - Institute for Immunology, University of Pennsylvania - Institute for Immunology and University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)
Downloads 29 (1,332,057)

Abstract:

Loading...

SARS-CoV-2, mRNA vaccine, dose interval, B cells, CD4+ T cells, CD8+ T cells, phenotype

7.

The Fc-Effector Function of COVID-19 Convalescent Plasma Contributes to SARS-CoV-2 Treatment Efficacy in Mice

Number of pages: 69 Posted: 27 Jun 2022
Irfan Ullah, Guillaume Beaudoin-Bussières, Kelly Symmes, Marc Cloutier, Eric Ducas, Alexandra Tauzin, Annemarie Laumaea, Philippe Begin, Walther Mothes, Priti Kumar, Renee Bazin, Andres Finzi and Pradeep Uchil
Yale University - Section of Infectious Diseases, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Yale University - Section of Infectious Diseases, Héma-Québec - Affaires Médicales et Innovation, Héma-Québec - Affaires Médicales et Innovation, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Montreal - Section of Allergy, Immunology and Rheumatology, Yale University - Department of Microbial Pathogenesis, Yale University - Section of Infectious Diseases, Héma-Québec - Affaires Médicales et Innovation, Centre de Recherche du CHUM and Yale University - Department of Microbial Pathogenesis
Downloads 29 (1,332,057)
Citation 1

Abstract:

Loading...

Fc-effector, convalescent plasma, ADCC, COVID-19, neutrophils, macrophages, SARS-CoV-2, IgG, IgM, IgA

8.

Reconstruction of a Polyclonal ADCC Antibody Repertoire from an HIV-1 Non-Transmitting Mother

Number of pages: 39 Posted: 15 Jan 2023
Zak A. Yaffe, Shilei Ding, Kevin Sung, Vrasha Chohan, Lorie Marchitto, Laura Doepker, Duncan Ralph, Ruth Nduati, Frederick A. Matsen, Andres Finzi, Julie Overbaugh and Sneak Peek Administrator
Fred Hutchinson Cancer Research Center - Human Biology Division, Centre de Recherche du CHUM, Fred Hutchinson Cancer Research Center - Public Health Sciences Division, Fred Hutchinson Cancer Research Center - Human Biology Division, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Fred Hutchinson Cancer Research Center - Human Biology Division, Fred Hutchinson Cancer Research Center - Public Health Sciences Division, Kenyatta National Hospital - Department of Paediatrics and Child Health, Fred Hutchinson Cancer Research Center - Public Health Sciences Division, Centre de Recherche du CHUM, Fred Hutchinson Cancer Research Center - Human Biology Division and Independent
Downloads 20 (1,448,301)

Abstract:

Loading...

Human immunodeficiency virus (HIV), antibody dependent cellular cytotoxicity (ADCC), vertical transmission, passive antibody transfer, maternal antibodies, pediatric HIV